Cardiac Magnetic Resonance in Cardiovascular Disease Research and Its Clinical Application: an Update

CHEN Yu-shu, GAO Fa-bao

Abstract

Cardiac magnetic resonance (CMR) is a non-invasive imaging technology, which has been used widely in clinical and basic researches on cardiovascular disease in recent years. With the innovation and optimization of CMR technologies, significant progress has been developed in the evaluation of myocardial viability, the function of regions and global myocardium, and the myocardial texture characteristics. Therefore, with the discussion on the progress of CMR to draw more and more attention in clinics, we hope to improve the application of CMR not only in the basic research but also in the diagnosis and precise evaluation aspects of cardiovascular disease.

 

Keywords: Cardiac magnetic resonance, Diagnosis, Non-invasive imaging tecnology, Myocardial texture characteristics

 

Full Text:

PDF


References


HUNDLEY WG, BLUEMKE DA, FINN JP. Et al. ACCF/ ACR/AHA/NASCI/SCMR 2010 expert consensus document on cardiovascular magnetic resonance; a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents. Circulation, 2010, 121 ( 22 ): 2462-2508.

PEREA RJ, ORTIZ-PEREZ JT. SOLE M. et al. T1 mapping; characterisation of myocardial interstitial space. Insights Imaging,2015 .6(2); 189-202.

GANDHI MS, KAMALOV G, SHAHBAZ AU, et al. Cellular and molecular pathways to myocardial necrosis and replacement fibrosis. Heart Fail Rev,2011,16( 1) :23-34. KIM RJ. FIENO DS, PARRISH ТВ, etal. Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age. and contractile function. Circulation, 1999, 100 (19):1992-2002.

PETERZAN MA, RIDER OJ, ANDERSON LJ. The role of cardiovascular magnetic resonance imaging in heart failure. Card Fail Rev,2016,2(2): 115-122.

AZARISMAN SM, CARBONE A, SHIRAZI M. et al. Characterisation of myocardial injury via T1 mapping in early reperfused myocardial infarction and its relationship with global and regional diastolic dysfunction. Heart Lung Circ, 2016,25(11): 1094-1106.

LIU X, YANG ZG, GAO Y, et al. Left ventricular subclinical myocardial dysfunction in uncomplicated type 2 diabetes mellitus is associated with impaired myocardial perfusion; a contrast-enhanced cardiovascular magnetic resonance study. Cardiovasc Diabetol, 2018, 17 ( 1 ): 139 [2019-03-18]. https://doi. org/10. 1186/sl2933-018-0782-0.

VO HQ. MARWICK TH. NEGISHI K. MRI-derived myocardial strain measures in normal subjects. JACC Cardiovasc Imaging,2018,11 (2 Pt 1); 196-205.

KOOSR. ALTIOK E. DOETSCH J, et al. Layer-specific strain-encoded MRI for the evaluation of left ventricular function and infarct transmurality in patients with chronic coronary artery disease. Int J Cardiol.2013.166(1) :85-89.

HINOJAR R, FERNANDEZ-GOLFIN C, GONZALEZ- GOMEZ A, et al. Prognostic implications of global myocardial mechanics in hypertrophic cardiomyopathy by cardiovascular magnetic resonance feature tracking. Relations to left ventricular hypertrophy and fibrosis. Int J Cardiol. 2017,249: 467-472[2019-03-18]. https;//doi. org/10. 1016/ j. ijcard. 2017.07.087.

CHIMURA M. ONISHI T. TSUKISHIRO Y. et al. Longitudinal strain combined with delayed-enhancement magnetic resonance improves risk stratification in patients with dilated cardiomyopathy. Heart ,2017,103(9) ; 679-686.

KIDO T, NAGAO M, KIDO T, et al. Stress/rest circumferential strain in non-ischemia, ischemia, and Infarction quantification by 3 Tesla tagged magnetic resonance imaging. Circ J ,2013*77(5) : 1235-1241.

DI MARCO A, ANGUERA I. SCHMITT M. et al. Late gadolinium enhancement and the risk for ventricular arrhythmias or sudden death in dilated cardiomyopathy: systematic review and meta-analysis. JACC Heart Fail.2017, 5(1):28-38.

WENG Z. YAO J, CHAN RH, et al. Prognostic value of LGE-CMR in HCM: a meta-analysis. JACC Cardiovasc Imaging,2016,9( 12): 1392-1402.

KIM RJ, CHEN EL, LIMA JA. et al. Myocardial Gd- DTPA kinetics determine MRI contrast enhancement and reflect the extent and severity of myocardial injury after acute reperfused infarction. Circulation» 1996»94( 12) :3318-3326.

PATEL H, MAZUR W, WILLIAMS KA. et al. Myocardial viability-state of the art; is it still relevant and how to best assess it with imaging? Trends Cardiovasc Med. 2018.28 <1):24-37.

HUNOLDP, SCHLOSSER T. VOGT FM, et al. Myocardial late enhancement in contrast-enhanced cardiac MRI; distinction between infarction scar and iion-infarctioii- related disease. AJR Am J Roentgenol. 2005, 184 ( 5 ); 1420- 1426.

BENITO EM. CABANELAS N. NUNEZ-GARCIA M. et al. Preferential regional distribution of atrial fibrosis in posterior wall around left inferior pulmonary vein as identified by late gadolinium enhancement cardiac magnetic resonance in patients with atrial fibrillation. Europace. 2018. 20 ( 12 ): 1959-1965.

OSHINSKI JN, YANG Z, JONES JR. et al. Imaging time after Gd-DTPA injection is critical in using delayed enhancement to determine infarct size accurately with magnetic resonance imaging. Circulation. 2001 . 104 ( 23 ): 2838-2812.

DALL’ARMELLINA E, KARIA N. LINDSAY AC, et al. Dynamic changes of edema and late gadolinium enhancement after acute myocardial infarction and their relationship to functional recovery and salvage index. Circ Cardiovasc Imaging.2011.4(3):228-236.

KIDAMBI A, MOTWANI M, UDDIN A, et al. Myocardial extracellular volume estimation by CMR predicts functional recovery following acute MI. JACC Cardiovasc Imaging. 2017.10(9):989-999.

SERAPHIM A, KNOTT KD. AUGUSTO J< et al. Quantitative cardiac MRI. J Magn Reson Imaging, 2019 [2019-03-18]. https://doi. org/10. 1002/jmri. 26789.

MOON JC, MESSROGHLI DR, KELLMAN P, et al. Myocardial T1 mapping and extracellular volume

quantification; a Society for Cardiovascular Magnetic Resonance ( SCMR ) and CMR Working Group of the European Society of Cardiology consensus statement. J Cardio'asc Magn Reson. 2013, 15; 92[2019-03-18]. https:// doi. org/10. 1186/1532-4 29x-15-92.

MAESTRINI V, TREIBEL ТА, WHITE SK, et al. T1 mapping for characterization of intracellular and extracellular myocardial diseases in heart failure. Curr Cardiovasc Imaging Rep,2014(7): 9287[2019-03-18]. lutps;//doi. org/10. 1007/ si 2410-014-9287-8.

VAN OORSCHOT JW, EL AIDI H, JANSEN OF LORKEERS SJ. et al. Endogenous assessment of chronic myocardial infarction with T ( lrho)-mapping in patients. J Cardios'asc Magn Reson,2014»16:104[2019-03-18]. https:// doi. org/10. 1186/si2968-014-0104-y.

WANG C, ZHENG J, SUN J, et al. Endogenous contrast Tlrho cardiac magnetic resonance for myocardial fibrosis in hypertrophic cardiomyopathy patients. J Cardiol, 2015, 66 (6):520-526.

ZHANG Y, ZENG W. CHEN W, et at. MR extracellular volume mapping and non-contrast Tlrho mapping allow early detection of myocardial fibrosis in diabetic monkeys. Eur Radiol ,2019,29(6): 3006-3016.

TESSA C, DEL MEGLIO J, LILLI A, et al. T1 and T2 mapping in the identification of acute myocardial injury in patients with NSTEMI. Radiol Med, 2018, 123 ( 12 ): 926- 934.

NASSENSTEIN K. NENSA F, SCHLOSSER T, et al. Cardiac MRI; T2-mapping versus T2-weighted dark-blood TSE imaging for myocardial edema visualization in acute myocardial infarction. Rofo,2014 ,186(2); 166-172.


Refbacks

  • There are currently no refbacks.